$LUCY
Innovative Eyewear Inc Stock $lucy

$lucy Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000182912624005415 Filed on August 12, 2024

Income Statement

Concept	2024 Q3	2024 Q2
Revenue		$308.7K
YoY Change		81.65%
Cost Of Revenue		$253.5K
YoY Change		26.91%
Gross Profit		$55.18K
YoY Change		-285.06%
Gross Profit Margin		17.87%
Selling, General & Admin		$1.738M
YoY Change		62.1%
% of Gross Profit		3149.43%
Research & Development		$256.8K
YoY Change		30.04%
% of Gross Profit		465.42%
Depreciation & Amortization		$38.29K
YoY Change		271.51%
% of Gross Profit		69.4%
Operating Expenses		$2.030M
YoY Change		55.58%
Operating Profit		-$1.974M
YoY Change		47.97%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net		$25.96K
YoY Change		-44.16%
Pretax Income		-$1.948M
YoY Change		51.04%
Income Tax		$0.00
% Of Pretax Income
Net Earnings		-$1.948M
YoY Change		51.3%
Net Earnings / Revenue		-631.2%
Basic Earnings Per Share		-$1.87
Diluted Earnings Per Share		-$1.87
COMMON SHARES
Basic Shares Outstanding	1.571M shares	17.50M shares
Diluted Shares Outstanding		1.044M shares

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments		$5.897M
YoY Change		-19.33%
Cash & Equivalents		$5.897M
Short-Term Investments
Other Short-Term Assets		$59.45K
YoY Change		64.04%
Inventory		$930.5K
Prepaid Expenses		$267.4K
Receivables		$61.61K
Other Receivables		$0.00
Total Short-Term Assets		$7.287M
YoY Change		-16.92%
LONG-TERM ASSETS
Property, Plant & Equipment		$130.6K
YoY Change		4.35%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets		$92.72K
YoY Change		12.08%
Total Long-Term Assets		$572.6K
YoY Change		0.56%
TOTAL ASSETS
Total Short-Term Assets		$7.287M
Total Long-Term Assets		$572.6K
Total Assets		$7.859M
YoY Change		-15.85%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$376.5K
YoY Change		151.03%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt		$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities		$494.6K
YoY Change		49.62%
LONG-TERM LIABILITIES
Long-Term Debt		$0.00
YoY Change
Other Long-Term Liabilities		$20.45K
YoY Change		-65.92%
Total Long-Term Liabilities		$20.45K
YoY Change		-65.92%
TOTAL LIABILITIES
Total Short-Term Liabilities		$494.6K
Total Long-Term Liabilities		$20.45K
Total Liabilities		$515.1K
YoY Change		32.57%
SHAREHOLDERS EQUITY
Retained Earnings		-$20.89M
YoY Change		60.38%
Common Stock		$15.00
YoY Change		-88.37%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity		$7.344M
YoY Change
Total Liabilities & Shareholders Equity		$7.859M
YoY Change		-15.85%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income		-$1.948M
YoY Change		51.3%
Depreciation, Depletion And Amortization		$38.29K
YoY Change		271.51%
Cash From Operating Activities		-$1.929M
YoY Change		4.85%
INVESTING ACTIVITIES
Capital Expenditures		$29.93K
YoY Change		-0.23%
Acquisitions
YoY Change
Other Investing Activities		$11.66K
YoY Change		-100.6%
Cash From Investing Activities		-$18.27K
YoY Change		-99.08%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		5.196M
YoY Change		-9.32%
NET CHANGE
Cash From Operating Activities		-1.929M
Cash From Investing Activities		-18.27K
Cash From Financing Activities		5.196M
Net Change In Cash		3.248M
YoY Change		70.07%
FREE CASH FLOW
Cash From Operating Activities		-$1.929M
Capital Expenditures		$29.93K
Free Cash Flow		-$1.959M
YoY Change		4.77%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity File Number EntityFileNumber	001-41392
	dei	Entity Registrant Name EntityRegistrantName	INNOVATIVE EYEWEAR, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	FL
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33181
	dei	City Area Code CityAreaCode	(954)
	dei	Local Phone Number LocalPhoneNumber	826-0329
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	1304475	usd
	us-gaap	Operating Expenses OperatingExpenses	4051076	usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001808377
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-0734861
	dei	Entity Address Address Line1 EntityAddressAddressLine1	11900 Biscayne Blvd.
	dei	Entity Address City Or Town EntityAddressCityOrTown	North Miami
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	1570569	shares
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5896889	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4287447	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	61613	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	93211	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	624486	usd
CY2023Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	35450	usd
CY2023Q4	us-gaap	Liabilities Liabilities	659936	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-16969415	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	5558826	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6218762	usd
CY2023Q2	us-gaap	Revenues Revenues	169929	usd
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q2	LUCY	Due From Tekcapital And Affiliates DueFromTekcapitalAndAffiliates		usd
CY2024Q2	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet		usd
CY2023Q4	LUCY	Due To Tekcapital And Affiliates DueToTekcapitalAndAffiliates		usd
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q2	us-gaap	Interest Expense InterestExpense		usd
	us-gaap	Interest Expense InterestExpense		usd
CY2024Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Forfeited StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited		shares
CY2024Q2	us-gaap	Stock Issued During Period Shares Restricted Stock Award Forfeited StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited		shares
	us-gaap	Other Noncash Expense OtherNoncashExpense		usd
	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions		usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets		usd
	LUCY	Loan Made To Tekcapital Europe Ltd.See Note6 LoanMadeToTekcapitalEuropeLtd.SeeNote6		usd
	LUCY	Repayment Of Amounts Loaned To Tekcapital Europe Ltd.See Note6 RepaymentOfAmountsLoanedToTekcapitalEuropeLtd.SeeNote6		usd
	LUCY	Purchases Of Debt Securities PurchasesOfDebtSecurities		usd
	LUCY	Proceeds From Second Public Offering ProceedsFromSecondPublicOffering		usd
	LUCY	Proceeds From Atthemarket Offerings ProceedsFromAtthemarketOfferings		usd
	LUCY	Proceeds From First Registered Direct Offering ProceedsFromFirstRegisteredDirectOffering		usd
	LUCY	Proceeds From Second Registered Direct Offering ProceedsFromSecondRegisteredDirectOffering		usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt		usd
	LUCY	Issuance Of Shares From Conversion Of Related Party Convertible Debt IssuanceOfSharesFromConversionOfRelatedPartyConvertibleDebt		usd
	LUCY	Issuance Of Shares For Prepayment To Brand Ambassador IssuanceOfSharesForPrepaymentToBrandAmbassador		usd
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs		usd
	LUCY	Allowance For Doubtful Accounts Receivable Other AllowanceForDoubtfulAccountsReceivableOther		usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths		usd
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	LUCY	Stock Issued During Period Shares Stock Option Exercised StockIssuedDuringPeriodSharesStockOptionExercised		shares
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 630
CY2024Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	267410	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	313648	usd
CY2024Q2	LUCY	Inventory Prepayment InventoryPrepayment	70779	usd
CY2023Q4	LUCY	Inventory Prepayment InventoryPrepayment	323520	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	930487	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	533239	usd
CY2023Q4	LUCY	Due From Tekcapital And Affiliates DueFromTekcapitalAndAffiliates	6256	usd
CY2024Q2	us-gaap	Other Assets Current OtherAssetsCurrent	59447	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	59447	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	7286625	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	5616768	usd
CY2024Q2	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	349195	usd
CY2023Q4	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	286429	usd
CY2023Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	88073	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	130645	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	154848	usd
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	92715	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	72644	usd
CY2024Q2	us-gaap	Assets Assets	7859180	usd
CY2023Q4	us-gaap	Assets Assets	6218762	usd
CY2024Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	376544	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	581986	usd
CY2024Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	42500	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	42500	usd
CY2024Q2	LUCY	Due To Tekcapital And Affiliates DueToTekcapitalAndAffiliates	75591	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	494635	usd
CY2024Q2	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	20450	usd
CY2024Q2	us-gaap	Liabilities Liabilities	515085	usd
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1527034	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1527034	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	747416	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	747416	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	15	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	7	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	28233205	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	22528234	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-20889125	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	7344095	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7859180	usd
CY2024Q2	us-gaap	Revenues Revenues	308682	usd
	us-gaap	Revenues Revenues	692153	usd
	us-gaap	Revenues Revenues	314850	usd
CY2024Q2	us-gaap	Cost Of Revenue CostOfRevenue	253506	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	199745	usd
	us-gaap	Cost Of Revenue CostOfRevenue	630026	usd
	us-gaap	Cost Of Revenue CostOfRevenue	334375	usd
CY2024Q2	us-gaap	Gross Profit GrossProfit	55176	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	-29816	usd
	us-gaap	Gross Profit GrossProfit	62127	usd
	us-gaap	Gross Profit GrossProfit	-19525	usd
CY2024Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1295299	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	968354	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2404245	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1962126	usd
CY2024Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	442433	usd
CY2023Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	103643	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1103728	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	362940	usd
CY2024Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	256802	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	197478	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	473103	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	348647	usd
CY2024Q2	us-gaap	Management Fee Expense ManagementFeeExpense	35000	usd
CY2023Q2	us-gaap	Management Fee Expense ManagementFeeExpense	35000	usd
	us-gaap	Management Fee Expense ManagementFeeExpense	70000	usd
	us-gaap	Management Fee Expense ManagementFeeExpense	70000	usd
CY2024Q2	us-gaap	Operating Expenses OperatingExpenses	2029534	usd
	us-gaap	Operating Expenses OperatingExpenses	2743713	usd
CY2024Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	25959	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	47586	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	69239	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	47662	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	1097	usd
	us-gaap	Interest Expense InterestExpense	3036	usd
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	25959	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	46489	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	69239	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	44626	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-1948399	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1287802	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3919710	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2718612	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1044211	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1044211	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	503670	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	503670	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	896685	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	896685	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	476357	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	476357	shares
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.87
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.87
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.56
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.56
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.37
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.37
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.71
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.71
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	5558826	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	81900	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	232154	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-1971311	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	3901569	usd
CY2024Q2	LUCY	Atthemarket Offerings AtthemarketOfferings	2324579	usd
CY2024Q2	LUCY	First Registered Direct Offering FirstRegisteredDirectOffering	737300	usd
CY2024Q2	LUCY	Second Registered Direct Offering SecondRegisteredDirectOffering	2134051	usd
CY2024Q2	LUCY	Issuance Of Shares To Brand Ambassador IssuanceOfSharesToBrandAmbassador	21690	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	173305	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	-1948399	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	7344095	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	4024429	usd
CY2023Q1	LUCY	Exercises Of Warrants By Stockholders ExercisesOfWarrantsByStockholders	1532250	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	424431	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-1430810	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	4550300	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	17650	usd
CY2023Q2	LUCY	Exercises Of Warrants By Stockholders ExercisesOfWarrantsByStockholders	1204200	usd
CY2023Q2	LUCY	Exercises Of Warrants Related To Private Placement Transaction ExercisesOfWarrantsRelatedToPrivatePlacementTransaction	391268	usd
CY2023Q2	LUCY	Second Public Offering SecondPublicOffering	4115688	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	-40180	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-1287802	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	8951124	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3919710	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2718612	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	59951	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	17816	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	15297	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	28979	usd
	us-gaap	Other Noncash Expense OtherNoncashExpense	3036	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	405459	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	384251	usd
	LUCY	Expenses Paid By Parent And Affiliates ExpensesPaidByParentAndAffiliates	157835	usd
	LUCY	Expenses Paid By Parent And Affiliates ExpensesPaidByParentAndAffiliates	151467	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-3687	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	5814	usd
	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	88073	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-50285	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	26211	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-205442	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-129714	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-96160	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	60603	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	144507	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	734042	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	10000	usd
	LUCY	Contract Assets And Liabilities ContractAssetsAndLiabilities	-3597	usd
	LUCY	Contract Assets And Liabilities ContractAssetsAndLiabilities	-1560	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3396689	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3086259	usd
	LUCY	Loan Made To Tekcapital Europe Ltd.See Note6 LoanMadeToTekcapitalEuropeLtd.SeeNote6	767940	usd
	LUCY	Repayment Of Amounts Loaned To Tekcapital Europe Ltd.See Note6 RepaymentOfAmountsLoanedToTekcapitalEuropeLtd.SeeNote6	-767940	usd
	LUCY	Purchases Of Debt Securities PurchasesOfDebtSecurities	1949204	usd
	LUCY	Payment To Acquire Patent Costs PaymentToAcquirePatentCosts	78063	usd
	LUCY	Payment To Acquire Patent Costs PaymentToAcquirePatentCosts	131622	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	35748	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	34435	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-113811	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2115261	usd
	LUCY	Proceeds From Second Public Offering ProceedsFromSecondPublicOffering	4115688	usd
	LUCY	Proceeds From Atthemarket Offerings ProceedsFromAtthemarketOfferings	2324579	usd
	LUCY	Proceeds From First Registered Direct Offering ProceedsFromFirstRegisteredDirectOffering	737300	usd
	LUCY	Proceeds From Second Registered Direct Offering ProceedsFromSecondRegisteredDirectOffering	2134051	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	3127718	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	17650	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	109499	usd
	LUCY	Repayment Of Amounts Due To Tekcapital And Affiliates RepaymentOfAmountsDueToTekcapitalAndAffiliates	75988	usd
	LUCY	Repayment Of Amounts Due To Tekcapital And Affiliates RepaymentOfAmountsDueToTekcapitalAndAffiliates	184701	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5119942	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6966856	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	1609442	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	1765336	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4287447	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3591109	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5896889	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5356445	usd
	LUCY	Expenses Paid For By Parent Reported As Increase In Due To Parent And Affiliates And Related Party Convertible Debt ExpensesPaidForByParentReportedAsIncreaseInDueToParentAndAffiliatesAndRelatedPartyConvertibleDebt	157835	usd
	LUCY	Expenses Paid For By Parent Reported As Increase In Due To Parent And Affiliates And Related Party Convertible Debt ExpensesPaidForByParentReportedAsIncreaseInDueToParentAndAffiliatesAndRelatedPartyConvertibleDebt	151467	usd
	LUCY	Issuance Of Shares From Conversion Of Related Party Convertible Debt IssuanceOfSharesFromConversionOfRelatedPartyConvertibleDebt	81900	usd
	LUCY	Issuance Of Shares For Prepayment To Brand Ambassador IssuanceOfSharesForPrepaymentToBrandAmbassador	21690	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_80A_eus-gaap--NatureOfOperations_zUdWN1ItN56j" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 1 – <span id="xdx_82C_z5YYmA3WYMfl">GENERAL INFORMATION</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Innovative Eyewear, Inc. (the “Company,” “us,” “we,” or “our”) is a corporation organized under the laws of the State of Florida that develops and sells cutting-edge eyeglasses and sunglasses, which are designed to allow our customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. The Company was founded by Lucyd Ltd., a portfolio company of Tekcapital Plc through Tekcapital Europe, Ltd. (collectively, together with Lucyd Ltd., “Tekcapital and Affiliates”), which owned approximately 19% of our issued and outstanding shares of common stock and was our largest shareholder as of June 30, 2024. Innovative Eyewear has licensed the exclusive rights to the Lucyd<sup>®</sup> brand from Lucyd Ltd., which includes the exclusive use of all of Lucyd’s intellectual property, including our main product, Lucyd Lyte<sup>®</sup> glasses.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84A_eus-gaap--UseOfEstimates_zhb8Hznylmgj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_865_zHXpT0E7ltBi">Use of Estimates</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates, particularly given the significant uncertainties associated with the current geopolitical and economic environment.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
	LUCY	Schedule Of Allowance For Doubtful Accounts Table Text Blok ScheduleOfAllowanceForDoubtfulAccountsTableTextBlok	<table cellpadding="0" cellspacing="0" id="xdx_88F_ecustom--ScheduleOfAllowanceForDoubtfulAccountsTableTextBlok_zvb3BEvz2C3k" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8BF_zf4sHf67H3Bk" style="display: none">Schedule of allowance for doubtful accounts</span></td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td> <td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; width: 76%; vertical-align: top">Balance at January 1</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td id="xdx_986_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20240101__20240630_zT3pffgRZwne" style="width: 9%; text-align: right" title="Balance at begining">25,772</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td id="xdx_988_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20230101__20230630_zJQvnSWHskY3" style="width: 9%; text-align: right" title="Balance at begining">92,646</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Bad debt expense (recovery)</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_98C_eus-gaap--ProvisionForDoubtfulAccounts_c20240101__20240630_pp0p0" style="text-align: right" title="Bad debt expense (recovery)">(3,687</td> <td style="text-align: left">)</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_98A_eus-gaap--ProvisionForDoubtfulAccounts_c20230101__20230630_pp0p0" style="text-align: right" title="Bad debt expense (recovery)">5,814</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top">Write-offs</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_98E_eus-gaap--AllowanceForDoubtfulAccountsReceivableWriteOffs_iN_pp0p0_di_c20240101__20240630_zbyH6ZoEbph6" style="text-align: right" title="Write-offs"><span style="-sec-ix-hidden: xdx2ixbrl0576">-</span></td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_989_eus-gaap--AllowanceForDoubtfulAccountsReceivableWriteOffs_iN_pp0p0_di_c20230101__20230630_zavKSMIRSXia" style="text-align: right" title="Write-offs">(142</td> <td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1pt; vertical-align: top">Other</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td id="xdx_987_ecustom--AllowanceForDoubtfulAccountsReceivableOther_c20240101__20240630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Other">217</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td id="xdx_985_ecustom--AllowanceForDoubtfulAccountsReceivableOther_c20230101__20230630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Other"><span style="-sec-ix-hidden: xdx2ixbrl0582">-</span></td> <td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 2.5pt; vertical-align: top">Balance at June 30</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td id="xdx_982_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20240101__20240630_zvdX5AoC2b9a" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance at end">22,302</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td id="xdx_98B_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20230101__20230630_zVRdQeDJGZ9j" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance at end">98,318</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	25772	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	92646	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-3687	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	5814	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	142	usd
	LUCY	Allowance For Doubtful Accounts Receivable Other AllowanceForDoubtfulAccountsReceivableOther	217	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	22302	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	98318	usd
	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	31637	usd
CY2024Q2	LUCY	Inventory Prepayment InventoryPrepayment	70779	usd
CY2023Q4	LUCY	Inventory Prepayment InventoryPrepayment	323520	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	15000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	15000	usd
CY2024Q1	LUCY	Restocking Fee RestockingFee	15	usd
CY2024Q2	LUCY	Allowance For Sales Returns AllowanceForSalesReturns	8536	usd
CY2023Q4	LUCY	Allowance For Sales Returns AllowanceForSalesReturns	40933	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	271573	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	235825	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	140928	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	80977	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	130645	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	154848	usd
CY2024Q2	us-gaap	Depreciation Depreciation	38292	usd
CY2023Q2	us-gaap	Depreciation Depreciation	18672	usd
	us-gaap	Depreciation Depreciation	59951	usd
	us-gaap	Depreciation Depreciation	28979	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	407295	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	329232	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-58100	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-42803	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	349195	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	286429	usd
CY2024Q2	us-gaap	Adjustment For Amortization AdjustmentForAmortization	7483	usd
CY2023Q2	us-gaap	Adjustment For Amortization AdjustmentForAmortization	11860	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	15297	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	17816	usd
CY2023Q1	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	61356	usd
CY2023Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	48143	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	436000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	834000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1290000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	1543000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	9907000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	14010000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	41.60
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	144726	shares
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y2M19D
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	8.40
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	500	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	21.84
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	30750	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	46.77
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	114476	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y1M20D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	57.44
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	83540	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P1Y5M15D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	usd
CY2024Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	293000	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P0Y8M15D
CY2024Q2	us-gaap	Restricted Stock Expense RestrictedStockExpense	5075	usd
	us-gaap	Restricted Stock Expense RestrictedStockExpense	10150	usd
CY2024Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions	8500	usd
CY2024Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	81900	usd
CY2024Q2	LUCY	Stock Grants Expenses StockGrantsExpenses	40950	usd
	LUCY	Stock Grants Expenses StockGrantsExpenses	40950	usd
CY2024Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions	40950	usd
CY2024Q2	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	2828	shares
CY2024Q2	us-gaap	Sale Of Stock Consideration Received Per Transaction SaleOfStockConsiderationReceivedPerTransaction	13000	usd
CY2024Q2	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	12000	usd
CY2024Q2	LUCY	Release Payment ReleasePayment	325000	usd
	LUCY	Release Payment ReleasePayment	325000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-1948399	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1287802	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3919710	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2718612	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1044211	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1044211	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	503670	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	503670	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	896685	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	896685	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	476357	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	476357	shares
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.87
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.87
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.56
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.56
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.37
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.37
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.71
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.71
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2024Q3	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	43535	shares
CY2024Q3	us-gaap	Sale Of Stock Consideration Received Per Transaction SaleOfStockConsiderationReceivedPerTransaction	252000	usd
CY2024Q3	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	242000	usd

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001829126-24-005415-index-headers.html	Edgar Link	pending
0001829126-24-005415-index.html	Edgar Link	pending
0001829126-24-005415.txt	Edgar Link	pending
0001829126-24-005415-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
img_001.jpg	Edgar Link	pending
innovative_10q.htm	Edgar Link	pending
innovative_ex31-1.htm	Edgar Link	pending
innovative_ex31-2.htm	Edgar Link	pending
innovative_ex32-1.htm	Edgar Link	pending
innovative_ex32-2.htm	Edgar Link	pending
lucy-20240630.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
lucy-20240630_cal.xml	Edgar Link	unprocessable
lucy-20240630_def.xml	Edgar Link	unprocessable
lucy-20240630_lab.xml	Edgar Link	unprocessable
lucy-20240630_pre.xml	Edgar Link	unprocessable
innovative_10q_htm.xml	Edgar Link	completed
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LUCY
Innovative Eyewear Inc Stock $lucy

2024 Q3 Form 10-Q Financial Statement

#000182912624005415 Filed on August 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LUCY Innovative Eyewear Inc Stock $lucy

2024 Q3 Form 10-Q Financial Statement

#000182912624005415 Filed on August 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LUCY
Innovative Eyewear Inc Stock $lucy